Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | -13.87 | -11.37 | -0.49 | 3.14 |
Depreciation/ Depletion | 2.66 | 2.05 | 1.59 | 1.20 |
Non- Cash Items | 1.65 | 1.48 | 0.92 | 1.76 |
Changesin Working Capital | -3.49 | 6.40 | -3.58 | -7.51 |
Cashfrom Operating Activities | -13.05 | -1.63 | -1.68 | -1.62 |
Capital Expenditures | -4.11 | -9.64 | -4.95 | -6.74 |
Other Investing Cash Flow Items Total | 0.02 | 0.01 | 0.00 | 0.02 |
Cashfrom Investing Activities | -4.09 | -9.64 | -4.94 | -6.72 |
Financing Cash Flow Items | -1.03 | -1.49 | -0.92 | -1.78 |
Issuance( Retirement)of Stock Net | 28.92 | 0.00 | 4.00 | - |
Issuance( Retirement)of Debt Net | -10.76 | 12.71 | 3.26 | 10.45 |
Cashfrom Financing Activities | 17.13 | 11.22 | 6.33 | 8.67 |
Net Changein Cash | -0.01 | -0.05 | -0.29 | 0.33 |
Cash Interest Paid | 1.59 | 1.49 | 0.92 | 1.78 |
Deferred Taxes | - | -1.98 | -1.21 | -2.14 |
Oxygenta Pharmaceutical Dividend Oxygenta Pharmaceutical Bonus Oxygenta Pharmaceutical News Oxygenta Pharmaceutical AGM Oxygenta Pharmaceutical Rights Oxygenta Pharmaceutical Splits Oxygenta Pharmaceutical Board Meetings Oxygenta Pharmaceutical Key Metrics Oxygenta Pharmaceutical Shareholdings Oxygenta Pharmaceutical Profit Loss Oxygenta Pharmaceutical Balance Sheet Oxygenta Pharmaceutical Q1 Results Oxygenta Pharmaceutical Q2 Results Oxygenta Pharmaceutical Q3 Results Oxygenta Pharmaceutical Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks